Early microglia activation in a mouse model of chronic glaucoma.
Changes in microglial cell activation and distribution are associated with neuronal decline in the central nervous system (CNS), particularly under pathological conditions. Activated microglia converge on the initial site of axonal degeneration in human glaucoma, yet their part in its pathophysiology remains unresolved. To begin with, it is unknown whether microglia activation precedes or is a late consequence of retinal ganglion cell (RGC) neurodegeneration. Here we address this critical element in DBA/2J (D2) mice, an established model of chronic inherited glaucoma, using as a control the congenic substrain DBA/2J Gpnmb(+/SjJ) (D2G), which is not affected by glaucoma. We analyzed the spatial distribution and timecourse of microglial changes in the retina, as well as within the proximal optic nerve prior to and throughout ages when neurodegeneration has been reported. Exclusively in D2 mice, we detected early microglia clustering in the inner central retina and unmyelinated optic nerve regions, with microglia activation peaking by 3 months of age. Between 5 and 8 months of age, activated microglia persisted and concentrated in the optic disc, but also localized to the retinal periphery. Collectively, our findings suggest microglia activation is an early alteration in the retina and optic nerve in D2 glaucoma, potentially contributing to disease onset or progression. Ultimately, detection of microglial activation may have value in early disease diagnosis, while modulation of microglial responses may alter disease progression.
Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, Utah 84132, USA. alebosco@neuro.utah.edu
Alejandra
A
Bosco
Michael R
MR
Steele
Monica L
ML
Vetter
D000818:Animals; D000073883:CX3C Chemokine Receptor 1; D004195:Disease Models, Animal; D018450:Disease Progression; D005901:Glaucoma / Q000503:physiopathology*; D006801:Humans; D007429:Intraocular Pressure; D051379:Mice; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D017628:Microglia / Q000166:cytology / Q000502:physiology*; D009900:Optic Nerve / Q000166:cytology / Q000254:growth & development / Q000503:physiopathology; D019707:Receptors, Chemokine / Q000235:genetics / Q000378:metabolism; D012160:Retina / Q000166:cytology / Q000254:growth & development / Q000503:physiopathology
D000073883:CX3C Chemokine Receptor 1; C471885:Cx3cr1 protein, mouse; D019707:Receptors, Chemokine
Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5196-201
20194762
J Cell Biol. 2007 Dec 31;179(7):1523-37
18158332
J Mol Neurosci. 2005;26(1):17-25
15968082
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1599-608
18385080
Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2649-61
16043833
J Comp Neurol. 2008 Mar 1;507(1):1128-40
18098136
BMC Neurosci. 2006 Oct 03;7:66
17018142
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3595-602
16877434
Exp Eye Res. 2005 Dec;81(6):700-9
15967434
Exp Eye Res. 1996 Dec;63(6):759-62
9068383
J Glaucoma. 2009 Jun-Jul;18(5):341-53
19525723
PLoS Genet. 2005 Jul;1(1):17-26
16103918
Science. 2002 Oct 25;298(5594):789-91
12399581
Nat Neurosci. 2007 Nov;10(11):1387-94
17965659
Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1249-54
18546005
Eur J Neurosci. 1991;3(12):1189-1207
12106219
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3656-63
16877440
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5151-62
14638711
Nat Genet. 1999 Apr;21(4):405-9
10192392
Prog Retin Eye Res. 2009 Sep;28(5):348-68
19560552
Blood. 1993 Mar 15;81(6):1607-13
7680921
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3649-58
18316698
J Leukoc Biol. 2007 Jun;81(6):1345-51
17405851
J Neurosci. 1984 Jan;4(1):151-60
6198491
Mol Vis. 2008 Aug 31;14:1600-13
18769561
Glia. 2007 Jul;55(9):942-53
17457855
J Neurosci. 2008 Jan 9;28(2):548-61
18184797
Nature. 2008 Feb 7;451(7179):720-4
18256671
Arch Ophthalmol. 1999 Aug;117(8):1050-6
10448748
Exp Eye Res. 2009 Apr;88(4):816-24
19105954
Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2962-8
12202516
Neuroscientist. 2003 Dec;9(6):485-95
14678581
J Cell Sci. 2000 Sep;113 ( Pt 17):3073-84
10934045
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2304-20
9804139
J Neurosci Res. 2001 Jun 1;64(5):523-32
11391707
Mol Immunol. 2004 Nov;41(11):1089-98
15476920
J Immunol. 2007 May 15;178(10):6557-66
17475886
Neuroscience. 2009 Feb 6;158(3):1039-48
18708126
Glia. 2002 Nov;40(2):164-74
12379904
J Cell Biol. 2005 Oct 24;171(2):313-25
16247030
Vis Neurosci. 2005 Sep-Oct;22(5):637-48
16332275
Neuron. 2009 Oct 15;64(1):110-22
19840553
J Comp Neurol. 2007 Jul 1;503(1):182-97
17480014
J Neurochem. 2004 Feb;88(4):844-56
14756805
Biochem Biophys Res Commun. 1996 Nov 1;228(1):29-37
8912632
Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2969-76
12202517
J Neuroimmunol. 2008 Jul 31;198(1-2):56-61
18508131
Glia. 2009 Jan 1;57(1):66-78
18661547
Nat Rev Neurosci. 2007 Jan;8(1):57-69
17180163
J Glaucoma. 2003 Feb;12(1):63-8
12567116
Brain Res Brain Res Rev. 2005 Apr;48(2):234-9
15850662
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4028-34
20375327
J Comp Neurol. 2009 Sep 1;516(1):1-19
19562764
Glia. 2000 Oct;32(1):91-101
10975914
Semin Immunopathol. 2009 Nov;31(4):513-25
19763574
Prog Brain Res. 2008;173:353-73
18929121
BMC Neurosci. 2006 Jul 13;7:54
16839421
J Cell Biol. 1983 Sep;97(3):703-12
6350319
J Neuroophthalmol. 2008 Jun;28(2):144-54
18562848
Cell. 2007 Dec 14;131(6):1164-78
18083105
Glia. 2010 May;58(7):768-79
20091786
J Immunol. 1998 Apr 1;160(7):3543-54
9531317
Am J Pathol. 2009 Jun;174(6):2310-23
19435787
J Physiol. 2008 May 15;586(10):2551-80
18388140
J Clin Invest. 1995 Jun;95(6):2954-62
7769138
J Biol Chem. 2005 Sep 2;280(35):31240-8
15985430
Invest Ophthalmol Vis Sci. 1998 May;39(6):951-62
9579474
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):745-51
17251473
BMC Genet. 2007 Jul 03;8:45
17608931
Ophthalmol Eye Dis. 2010 Mar 11;1:23-41
20352036
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3005-10
12824245
Nat Neurosci. 2006 Feb;9(2):251-9
16415865
Exp Brain Res. 2000 Jun;132(4):476-84
10912828
BMC Genet. 2008 Apr 10;9:30
18402690
Neuroscience. 2006;139(4):1249-61
16567053
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):977-85
16505032
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):638-45
12556393
Prog Retin Eye Res. 2005 Nov;24(6):639-62
15953750
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3869-75
16186376
Nat Genet. 2002 Jan;30(1):81-5
11743578
J Exp Med. 2003 May 19;197(10):1335-44
12756269
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):466-72
14744886
Arch Ophthalmol. 1983 Aug;101(8):1301-2
6882262
J Neurosci. 2008 Mar 12;28(11):2735-44
18337403
J Leukoc Biol. 2009 Mar;85(3):352-70
19028958
J Neurosci Res. 2003 Sep 15;73(6):840-5
12949910
J Neuroimmunol. 2009 Dec 10;217(1-2):74-9
19850359
J Comp Neurol. 2008 Sep 20;510(3):237-50
18626943
J Comp Neurol. 2008 Jan 10;506(2):224-39
18022954
Acta Neuropathol. 2004 Apr;107(4):352-8
14745571
Lancet. 1984 Mar 24;1(8378):652-4
6199635
Stroke. 2001 May;32(5):1208-15
11340235
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4444-51
19443728
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1437-46
18385061
Cell. 2003 Jun 27;113(7):817-20
12837239
Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5567-81
18055806
Mol Vis. 2005 Mar 31;11:225-31
15827548
Biochem Biophys Res Commun. 1996 Jul 25;224(3):855-62
8713135
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4169-76
18487378
J Comp Neurol. 2007 Apr 20;501(6):866-78
17311318
Brain. 2009 Feb;132(Pt 2):288-95
18567623
Mol Vis. 2006 May 10;12:467-77
16710171
Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1493-504
19641932
Neuron. 2007 Feb 1;53(3):337-51
17270732
Glia. 1997 Nov;21(3):259-68
9383035
J Cell Biol. 1983 Jul;97(1):253-7
6345555
J Neurosci. 1998 Apr 1;18(7):2506-19
9502811
Invest Ophthalmol Vis Sci. 1986 Jul;27(7):1015-26
3721781
Exp Eye Res. 2007 Jan;84(1):13-21
17074320
Glia. 2010 May;58(7):780-9
20091782
Brain Res Bull. 2010 Feb 15;81(2-3):349-58
19379796
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):986-96
16505033
Can J Ophthalmol. 2007 Apr;42(2):278-87
17392853
FEBS Lett. 2002 Mar 13;514(2-3):115-21
11943136
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3161-77
17591886
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4564-72
17898279
Exp Eye Res. 1985 Sep;41(3):299-304
3905423